Literature DB >> 29395090

Point-of-care testing: A position statement from the Canadian Society of Clinical Chemists.

P M Yip1, A A Venner2, J Shea3, A Fuezery4, Y Huang5, L Massicotte6, N Tetreault7, C Tomalty8, J L V Shaw9.   

Abstract

Mesh：

Year:  2018        PMID： 29395090     DOI： 10.1016/j.clinbiochem.2018.01.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN： 0009-9120            Impact factor:   3.281


× No keyword cloud information.
  5 in total

Review 1. 

Authors:  Paul Van Caeseele; Dana Bailey; Sarah E Forgie; Tanis C Dingle; Mel Krajden
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

Review 2.  Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology.

Authors:  Dana Bailey; Danijela Konforte; Vilte E Barakauskas; Paul M Yip; Vathany Kulasingam; Mohamed Abou El Hassan; Lori A Beach; Ivan M Blasutig; Peter Catomeris; Kent C Dooley; Yanping Gong; Peter Kavsak; Edward W Randell; Jason L Robinson; Julie Shaw; Jennifer Taher; Nicole White-Al Habeeb
Journal:  Clin Biochem       Date:  2020-10-06       Impact factor: 3.281

3.  Improving quality of transcutaneous bilirubin measurements: Value of in-house developed quality control.

Authors:  Heather Anne Paul; Brenda Joanne Adams; Allison Anne Venner
Journal:  Pract Lab Med       Date:  2021-01-28

4.  Identifying sources of error and selecting quality indicators for point of care testing.

Authors:  Miranda Brun; Anna K Füzéry; Bailey Henschke; Kallie Rozak; Allison A Venner
Journal:  Pract Lab Med       Date:  2021-03-21

Review 5.  Communications with lab and POCT users.

Authors:  James Dalton
Journal:  Pract Lab Med       Date:  2021-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.